

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.52948163 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.52948163 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.16304413 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.16304413 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.81668078 |
| 6 | angiotensin maturation (GO:0002003) | 6.66268452 |
| 7 | regulation of guanylate cyclase activity (GO:0031282) | 6.43250506 |
| 8 | tryptophan catabolic process (GO:0006569) | 6.18440270 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 6.18440270 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 6.18440270 |
| 11 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.02575871 |
| 12 | kynurenine metabolic process (GO:0070189) | 5.92661559 |
| 13 | bile acid biosynthetic process (GO:0006699) | 5.83011800 |
| 14 | glyoxylate metabolic process (GO:0046487) | 5.80569125 |
| 15 | tryptophan metabolic process (GO:0006568) | 5.80241669 |
| 16 | cysteine metabolic process (GO:0006534) | 5.47908595 |
| 17 | urea metabolic process (GO:0019627) | 5.39819292 |
| 18 | urea cycle (GO:0000050) | 5.39819292 |
| 19 | high-density lipoprotein particle remodeling (GO:0034375) | 5.26231997 |
| 20 | alpha-linolenic acid metabolic process (GO:0036109) | 5.24075903 |
| 21 | sulfur amino acid catabolic process (GO:0000098) | 5.22722870 |
| 22 | serine family amino acid catabolic process (GO:0009071) | 5.20455569 |
| 23 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 5.19637762 |
| 24 | positive regulation of guanylate cyclase activity (GO:0031284) | 5.12885666 |
| 25 | negative regulation of fibrinolysis (GO:0051918) | 5.08988263 |
| 26 | protein carboxylation (GO:0018214) | 5.06080593 |
| 27 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.06080593 |
| 28 | regulation of fibrinolysis (GO:0051917) | 5.03339766 |
| 29 | bile acid metabolic process (GO:0008206) | 5.01646112 |
| 30 | aromatic amino acid family metabolic process (GO:0009072) | 5.00330010 |
| 31 | nitrogen cycle metabolic process (GO:0071941) | 4.99547136 |
| 32 | complement activation, alternative pathway (GO:0006957) | 4.95544638 |
| 33 | regulation of protein activation cascade (GO:2000257) | 4.92094386 |
| 34 | homocysteine metabolic process (GO:0050667) | 4.87135980 |
| 35 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.86043371 |
| 36 | regulation of triglyceride catabolic process (GO:0010896) | 4.83440542 |
| 37 | intestinal absorption (GO:0050892) | 4.79913658 |
| 38 | amino-acid betaine metabolic process (GO:0006577) | 4.73351689 |
| 39 | tyrosine metabolic process (GO:0006570) | 4.69787688 |
| 40 | regulation of cholesterol esterification (GO:0010872) | 4.68813559 |
| 41 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.68246320 |
| 42 | cellular ketone body metabolic process (GO:0046950) | 4.62947556 |
| 43 | lysine metabolic process (GO:0006553) | 4.60941625 |
| 44 | lysine catabolic process (GO:0006554) | 4.60941625 |
| 45 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.60506094 |
| 46 | alpha-amino acid catabolic process (GO:1901606) | 4.60334019 |
| 47 | regulation of complement activation (GO:0030449) | 4.59416984 |
| 48 | triglyceride homeostasis (GO:0070328) | 4.54484822 |
| 49 | acylglycerol homeostasis (GO:0055090) | 4.54484822 |
| 50 | reverse cholesterol transport (GO:0043691) | 4.53089200 |
| 51 | protein-lipid complex remodeling (GO:0034368) | 4.50494570 |
| 52 | macromolecular complex remodeling (GO:0034367) | 4.50494570 |
| 53 | plasma lipoprotein particle remodeling (GO:0034369) | 4.50494570 |
| 54 | regulation of cellular extravasation (GO:0002691) | 4.45747622 |
| 55 | indolalkylamine metabolic process (GO:0006586) | 4.43802355 |
| 56 | phospholipid efflux (GO:0033700) | 4.42334926 |
| 57 | negative regulation of sterol transport (GO:0032372) | 4.40576143 |
| 58 | negative regulation of cholesterol transport (GO:0032375) | 4.40576143 |
| 59 | positive regulation of respiratory burst (GO:0060267) | 4.40143388 |
| 60 | bile acid and bile salt transport (GO:0015721) | 4.38331375 |
| 61 | amine catabolic process (GO:0009310) | 4.34221139 |
| 62 | cellular biogenic amine catabolic process (GO:0042402) | 4.34221139 |
| 63 | coenzyme catabolic process (GO:0009109) | 4.34019654 |
| 64 | glycine metabolic process (GO:0006544) | 4.33991437 |
| 65 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.29875610 |
| 66 | serine family amino acid metabolic process (GO:0009069) | 4.28759511 |
| 67 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.26692369 |
| 68 | cellular amino acid catabolic process (GO:0009063) | 4.26498959 |
| 69 | cellular glucuronidation (GO:0052695) | 4.21753416 |
| 70 | drug catabolic process (GO:0042737) | 4.20355881 |
| 71 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.17753262 |
| 72 | plasma lipoprotein particle clearance (GO:0034381) | 4.15244436 |
| 73 | glutamate metabolic process (GO:0006536) | 4.14774439 |
| 74 | imidazole-containing compound metabolic process (GO:0052803) | 4.11056183 |
| 75 | benzene-containing compound metabolic process (GO:0042537) | 4.09917211 |
| 76 | regulation of vitamin metabolic process (GO:0030656) | 4.08004231 |
| 77 | serine family amino acid biosynthetic process (GO:0009070) | 4.07833419 |
| 78 | cholesterol efflux (GO:0033344) | 4.02812908 |
| 79 | ketone body metabolic process (GO:1902224) | 4.00977069 |
| 80 | cellular modified amino acid catabolic process (GO:0042219) | 3.95514411 |
| 81 | short-chain fatty acid metabolic process (GO:0046459) | 3.95083553 |
| 82 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.93798616 |
| 83 | endocrine process (GO:0050886) | 3.93798616 |
| 84 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.93798616 |
| 85 | ethanol oxidation (GO:0006069) | 3.93564001 |
| 86 | regulation of bile acid biosynthetic process (GO:0070857) | 3.90783653 |
| 87 | negative regulation of lipase activity (GO:0060192) | 3.89941952 |
| 88 | fibrinolysis (GO:0042730) | 3.89522769 |
| 89 | aldehyde catabolic process (GO:0046185) | 3.89181687 |
| 90 | arginine metabolic process (GO:0006525) | 3.88653858 |
| 91 | vitamin A metabolic process (GO:0006776) | 3.87059517 |
| 92 | glucuronate metabolic process (GO:0019585) | 3.83076815 |
| 93 | uronic acid metabolic process (GO:0006063) | 3.83076815 |
| 94 | epoxygenase P450 pathway (GO:0019373) | 3.81436449 |
| 95 | acetyl-CoA metabolic process (GO:0006084) | 3.81179025 |
| 96 | organic acid catabolic process (GO:0016054) | 3.80210211 |
| 97 | carboxylic acid catabolic process (GO:0046395) | 3.80210211 |
| 98 | drug transmembrane transport (GO:0006855) | 3.75334335 |
| 99 | urate metabolic process (GO:0046415) | 3.74940995 |
| 100 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.74384549 |
| 101 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.74384549 |
| 102 | plasma lipoprotein particle assembly (GO:0034377) | 3.74210174 |
| 103 | low-density lipoprotein particle remodeling (GO:0034374) | 3.71704960 |
| 104 | cholesterol homeostasis (GO:0042632) | 3.70958217 |
| 105 | blood coagulation, intrinsic pathway (GO:0007597) | 3.69208472 |
| 106 | cofactor catabolic process (GO:0051187) | 3.69182369 |
| 107 | exogenous drug catabolic process (GO:0042738) | 3.68080902 |
| 108 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.67080820 |
| 109 | sterol homeostasis (GO:0055092) | 3.65418429 |
| 110 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.65048509 |
| 111 | regulation of cGMP biosynthetic process (GO:0030826) | 3.64939729 |
| 112 | lipoprotein transport (GO:0042953) | 3.63373677 |
| 113 | eosinophil chemotaxis (GO:0048245) | 3.62764812 |
| 114 | regulation of cholesterol homeostasis (GO:2000188) | 3.60461134 |
| 115 | positive regulation of lipid catabolic process (GO:0050996) | 3.59064173 |
| 116 | antibacterial humoral response (GO:0019731) | 3.57724885 |
| 117 | sulfate transmembrane transport (GO:1902358) | 3.57211308 |
| 118 | antimicrobial humoral response (GO:0019730) | 3.57080377 |
| 119 | positive regulation of pseudopodium assembly (GO:0031274) | 3.56820373 |
| 120 | flavonoid metabolic process (GO:0009812) | 3.55643764 |
| 121 | very long-chain fatty acid metabolic process (GO:0000038) | 3.55600986 |
| 122 | monocarboxylic acid catabolic process (GO:0072329) | 3.53776906 |
| 123 | fatty acid oxidation (GO:0019395) | 3.53260833 |
| 124 | renal system process involved in regulation of blood volume (GO:0001977) | 3.52294145 |
| 125 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.51881283 |
| 126 | carnitine metabolic process (GO:0009437) | 3.51192197 |
| 127 | aspartate family amino acid catabolic process (GO:0009068) | 3.50675447 |
| 128 | desmosome organization (GO:0002934) | 3.43988759 |
| 129 | peptide catabolic process (GO:0043171) | 3.40901676 |
| 130 | regulation of systemic arterial blood pressure (GO:0003073) | 3.40371507 |
| 131 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.40363879 |
| 132 | regulation of cGMP metabolic process (GO:0030823) | 3.39244011 |
| 133 | hormone catabolic process (GO:0042447) | 3.29279032 |
| 134 | NADH metabolic process (GO:0006734) | 3.25222676 |
| 135 | eosinophil migration (GO:0072677) | 3.19541679 |
| 136 | regulation of antigen processing and presentation (GO:0002577) | 3.17694018 |
| 137 | adhesion of symbiont to host cell (GO:0044650) | 3.11937527 |
| 138 | virion attachment to host cell (GO:0019062) | 3.11937527 |
| 139 | regulation of pseudopodium assembly (GO:0031272) | 3.11059840 |
| 140 | oligosaccharide biosynthetic process (GO:0009312) | 3.09649619 |
| 141 | regulation of respiratory burst (GO:0060263) | 3.05395937 |
| 142 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.04105306 |
| 143 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.03585216 |
| 144 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.02130091 |
| 145 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 3.00849531 |
| 146 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.99865873 |
| 147 | L-fucose catabolic process (GO:0042355) | 2.94201567 |
| 148 | fucose catabolic process (GO:0019317) | 2.94201567 |
| 149 | L-fucose metabolic process (GO:0042354) | 2.94201567 |
| 150 | transcytosis (GO:0045056) | 2.93062494 |
| 151 | peptide hormone processing (GO:0016486) | 2.92747634 |
| 152 | positive regulation of antigen processing and presentation (GO:0002579) | 2.92498908 |
| 153 | glomerular filtration (GO:0003094) | 2.87366413 |
| 154 | cytidine metabolic process (GO:0046087) | 2.87306139 |
| 155 | cytidine catabolic process (GO:0006216) | 2.87306139 |
| 156 | cytidine deamination (GO:0009972) | 2.87306139 |
| 157 | glycosphingolipid catabolic process (GO:0046479) | 2.87277782 |
| 158 | fructose metabolic process (GO:0006000) | 2.84422631 |
| 159 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 2.83445636 |
| 160 | drug metabolic process (GO:0017144) | 2.82992199 |
| 161 | sulfate transport (GO:0008272) | 2.82891491 |
| 162 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.80725790 |
| 163 | glycolipid catabolic process (GO:0019377) | 2.79413176 |
| 164 | T cell costimulation (GO:0031295) | 2.79136741 |
| 165 | regulation of regulatory T cell differentiation (GO:0045589) | 2.77255331 |
| 166 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.76615993 |
| 167 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.75918225 |
| 168 | lymphocyte costimulation (GO:0031294) | 2.75045604 |
| 169 | sulfur compound transport (GO:0072348) | 2.71044888 |
| 170 | digestion (GO:0007586) | 2.70922923 |
| 171 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.70919364 |
| 172 | positive regulation of cGMP biosynthetic process (GO:0030828) | 2.69810617 |
| 173 | renal filtration (GO:0097205) | 2.68466444 |
| 174 | thrombin receptor signaling pathway (GO:0070493) | 2.64988278 |
| 175 | O-glycan processing (GO:0016266) | 2.64819878 |
| 176 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.64769329 |
| 177 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.64769329 |
| 178 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.63188658 |
| 179 | digestive system process (GO:0022600) | 2.61927873 |
| 180 | immunoglobulin mediated immune response (GO:0016064) | 2.61043330 |
| 181 | fucosylation (GO:0036065) | 2.55682446 |
| 182 | intermediate filament organization (GO:0045109) | 2.55415606 |
| 183 | NIK/NF-kappaB signaling (GO:0038061) | 2.55262992 |
| 184 | glycosylceramide metabolic process (GO:0006677) | 2.53542558 |
| 185 | regulation of protein glycosylation (GO:0060049) | 2.53450515 |
| 186 | intestinal epithelial cell development (GO:0060576) | 2.52766624 |
| 187 | diacylglycerol metabolic process (GO:0046339) | 2.49982305 |
| 188 | fat-soluble vitamin metabolic process (GO:0006775) | 2.48241119 |
| 189 | negative regulation of cell killing (GO:0031342) | 2.47217192 |
| 190 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.47217192 |
| 191 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.46635372 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.85692171 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.78058368 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.70521492 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.11212588 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.93307435 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.79751133 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.73238507 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.54418423 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.67463157 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.62831466 |
| 11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.85200767 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.39395742 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.37606214 |
| 14 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.25503263 |
| 15 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.24708230 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.11311961 |
| 17 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.09970371 |
| 18 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.1517853 |
| 19 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.96349134 |
| 20 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.96235846 |
| 21 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.92988822 |
| 22 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.84226706 |
| 23 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.75410871 |
| 24 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.69893064 |
| 25 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.69356599 |
| 26 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.69276230 |
| 27 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.65374471 |
| 28 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.55366309 |
| 29 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.48215091 |
| 30 | MYB_26560356_Chip-Seq_TH2_Human | 1.47475711 |
| 31 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.46232778 |
| 32 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.38969602 |
| 33 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.34547575 |
| 34 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.34290358 |
| 35 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.32653232 |
| 36 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.32262321 |
| 37 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.28269251 |
| 38 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.26703473 |
| 39 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.23013019 |
| 40 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.22866354 |
| 41 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.22784052 |
| 42 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.22013088 |
| 43 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.21880900 |
| 44 | MYB_26560356_Chip-Seq_TH1_Human | 1.20740471 |
| 45 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.18618649 |
| 46 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.17754952 |
| 47 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.17743004 |
| 48 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.17698677 |
| 49 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.17596661 |
| 50 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.16728077 |
| 51 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.16552135 |
| 52 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.16072253 |
| 53 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.15939222 |
| 54 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.15199636 |
| 55 | GATA3_26560356_Chip-Seq_TH2_Human | 1.11940091 |
| 56 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11736805 |
| 57 | GATA2_19941826_ChIP-Seq_K562_Human | 1.11599303 |
| 58 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.11585515 |
| 59 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.10675075 |
| 60 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.08073632 |
| 61 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07961459 |
| 62 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.07141109 |
| 63 | GATA1_19941826_ChIP-Seq_K562_Human | 1.05546707 |
| 64 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.04911154 |
| 65 | VDR_22108803_ChIP-Seq_LS180_Human | 1.03159907 |
| 66 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.01318178 |
| 67 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98107747 |
| 68 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.97463254 |
| 69 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.97221228 |
| 70 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.96512029 |
| 71 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.96129340 |
| 72 | GATA1_22025678_ChIP-Seq_K562_Human | 0.95552277 |
| 73 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.92855161 |
| 74 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.92785309 |
| 75 | P300_27268052_Chip-Seq_Bcells_Human | 0.92133984 |
| 76 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.91927888 |
| 77 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.90624022 |
| 78 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.89855166 |
| 79 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.89676695 |
| 80 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.88802665 |
| 81 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.87767892 |
| 82 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.87435245 |
| 83 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87139841 |
| 84 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.86004172 |
| 85 | CJUN_26792858_Chip-Seq_BT549_Human | 0.85800842 |
| 86 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.85792693 |
| 87 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84393210 |
| 88 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83737333 |
| 89 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.83538463 |
| 90 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.83394159 |
| 91 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.82772242 |
| 92 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.82708375 |
| 93 | SA1_27219007_Chip-Seq_Bcells_Human | 0.82240395 |
| 94 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.81902433 |
| 95 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.79538531 |
| 96 | RXR_22108803_ChIP-Seq_LS180_Human | 0.79516449 |
| 97 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.79424279 |
| 98 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.77026712 |
| 99 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.76432510 |
| 100 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.75182276 |
| 101 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.75182276 |
| 102 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.74454753 |
| 103 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.71846461 |
| 104 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.70921095 |
| 105 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.69893289 |
| 106 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.69393193 |
| 107 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.69331869 |
| 108 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.69075237 |
| 109 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.68438303 |
| 110 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.67643948 |
| 111 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.65990776 |
| 112 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.65147106 |
| 113 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.65128726 |
| 114 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.64816426 |
| 115 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.63634845 |
| 116 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.63619430 |
| 117 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.63591456 |
| 118 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.62202158 |
| 119 | CBP_21632823_ChIP-Seq_H3396_Human | 0.62174188 |
| 120 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.61456349 |
| 121 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.60337762 |
| 122 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.60248787 |
| 123 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.59993541 |
| 124 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.59775272 |
| 125 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.59087249 |
| 126 | AR_20517297_ChIP-Seq_VCAP_Human | 0.58625136 |
| 127 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.58613217 |
| 128 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.58095314 |
| 129 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.57924109 |
| 130 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.57127615 |
| 131 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.55342713 |
| 132 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.54961044 |
| 133 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.54902329 |
| 134 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.54582278 |
| 135 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.54441762 |
| 136 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.54178100 |
| 137 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.53705984 |
| 138 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.52665287 |
| 139 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.52640764 |
| 140 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.52443402 |
| 141 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.52423269 |
| 142 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.52307208 |
| 143 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.52114977 |
| 144 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.51442406 |
| 145 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.50901427 |
| 146 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.50493743 |
| 147 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.50460086 |
| 148 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.50447696 |
| 149 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.49918494 |
| 150 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.49885092 |
| 151 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.49628741 |
| 152 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.47718029 |
| 153 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.47685514 |
| 154 | NCOR_22424771_ChIP-Seq_293T_Human | 0.47190121 |
| 155 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.47142396 |
| 156 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.46001825 |
| 157 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.45934505 |
| 158 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.45449200 |
| 159 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.44730534 |
| 160 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.43903814 |
| 161 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.43853282 |
| 162 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.42708928 |
| 163 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.42485187 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.18075834 |
| 2 | MP0005360_urolithiasis | 7.72889607 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.30218063 |
| 4 | MP0005365_abnormal_bile_salt | 5.99009837 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.11267055 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.87241629 |
| 7 | MP0003252_abnormal_bile_duct | 3.77397956 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.40281634 |
| 9 | MP0009840_abnormal_foam_cell | 3.25157652 |
| 10 | MP0010155_abnormal_intestine_physiology | 3.17204162 |
| 11 | MP0001873_stomach_inflammation | 3.03033361 |
| 12 | MP0005332_abnormal_amino_acid | 2.95511149 |
| 13 | MP0003195_calcinosis | 2.89026200 |
| 14 | MP0005083_abnormal_biliary_tract | 2.84687691 |
| 15 | MP0003183_abnormal_peptide_metabolism | 2.82895414 |
| 16 | MP0001666_abnormal_nutrient_absorption | 2.67677396 |
| 17 | MP0004019_abnormal_vitamin_homeostasis | 2.55156135 |
| 18 | MP0003866_abnormal_defecation | 2.51286404 |
| 19 | MP0004264_abnormal_extraembryonic_tissu | 2.29667415 |
| 20 | MP0005451_abnormal_body_composition | 2.20316908 |
| 21 | MP0005671_abnormal_response_to | 2.13127004 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 2.11564646 |
| 23 | MP0004147_increased_porphyrin_level | 2.10323356 |
| 24 | MP0002118_abnormal_lipid_homeostasis | 2.09038623 |
| 25 | MP0001790_abnormal_immune_system | 2.08301665 |
| 26 | MP0005387_immune_system_phenotype | 2.08301665 |
| 27 | MP0000609_abnormal_liver_physiology | 2.01541904 |
| 28 | MP0002138_abnormal_hepatobiliary_system | 1.97413570 |
| 29 | MP0001663_abnormal_digestive_system | 1.90945768 |
| 30 | MP0001835_abnormal_antigen_presentation | 1.90011312 |
| 31 | MP0003300_gastrointestinal_ulcer | 1.84734262 |
| 32 | MP0001800_abnormal_humoral_immune | 1.84508093 |
| 33 | MP0000490_abnormal_crypts_of | 1.84074659 |
| 34 | MP0003303_peritoneal_inflammation | 1.82565796 |
| 35 | MP0003868_abnormal_feces_composition | 1.81916136 |
| 36 | MP0009785_altered_susceptibility_to | 1.81402130 |
| 37 | MP0003763_abnormal_thymus_physiology | 1.69405937 |
| 38 | MP0005319_abnormal_enzyme/_coenzyme | 1.69067280 |
| 39 | MP0001764_abnormal_homeostasis | 1.66438245 |
| 40 | MP0004947_skin_inflammation | 1.65491456 |
| 41 | MP0000465_gastrointestinal_hemorrhage | 1.63203769 |
| 42 | MP0002148_abnormal_hypersensitivity_rea | 1.59839075 |
| 43 | MP0000685_abnormal_immune_system | 1.59190313 |
| 44 | MP0005310_abnormal_salivary_gland | 1.56984138 |
| 45 | MP0003011_delayed_dark_adaptation | 1.55242043 |
| 46 | MP0009697_abnormal_copulation | 1.54301767 |
| 47 | MP0005025_abnormal_response_to | 1.52912180 |
| 48 | MP0005000_abnormal_immune_tolerance | 1.52245219 |
| 49 | MP0010352_gastrointestinal_tract_polyps | 1.50995856 |
| 50 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.49994186 |
| 51 | MP0009333_abnormal_splenocyte_physiolog | 1.49890163 |
| 52 | MP0001664_abnormal_digestion | 1.48038023 |
| 53 | MP0001845_abnormal_inflammatory_respons | 1.47167931 |
| 54 | MP0005381_digestive/alimentary_phenotyp | 1.46383785 |
| 55 | MP0002452_abnormal_antigen_presenting | 1.45482178 |
| 56 | MP0002723_abnormal_immune_serum | 1.43252376 |
| 57 | MP0003436_decreased_susceptibility_to | 1.41494181 |
| 58 | MP0009643_abnormal_urine_homeostasis | 1.38416957 |
| 59 | MP0006082_CNS_inflammation | 1.32010615 |
| 60 | MP0001819_abnormal_immune_cell | 1.29326515 |
| 61 | MP0002420_abnormal_adaptive_immunity | 1.28391009 |
| 62 | MP0000477_abnormal_intestine_morphology | 1.28281919 |
| 63 | MP0001501_abnormal_sleep_pattern | 1.27836033 |
| 64 | MP0000678_abnormal_parathyroid_gland | 1.27475666 |
| 65 | MP0003186_abnormal_redox_activity | 1.17119567 |
| 66 | MP0005647_abnormal_sex_gland | 1.17058748 |
| 67 | MP0002254_reproductive_system_inflammat | 1.12028848 |
| 68 | MP0004381_abnormal_hair_follicle | 1.11775398 |
| 69 | MP0005636_abnormal_mineral_homeostasis | 1.08823733 |
| 70 | MP0002166_altered_tumor_susceptibility | 1.06798869 |
| 71 | MP0002796_impaired_skin_barrier | 1.06279935 |
| 72 | MP0002419_abnormal_innate_immunity | 1.04644046 |
| 73 | MP0000604_amyloidosis | 1.01332937 |
| 74 | MP0009764_decreased_sensitivity_to | 0.99410864 |
| 75 | MP0003656_abnormal_erythrocyte_physiolo | 0.98785912 |
| 76 | MP0000598_abnormal_liver_morphology | 0.97888352 |
| 77 | MP0005410_abnormal_fertilization | 0.96923053 |
| 78 | MP0002876_abnormal_thyroid_physiology | 0.93876573 |
| 79 | MP0000716_abnormal_immune_system | 0.93467953 |
| 80 | MP0005174_abnormal_tail_pigmentation | 0.91622030 |
| 81 | MP0003718_maternal_effect | 0.90620718 |
| 82 | MP0005408_hypopigmentation | 0.89803445 |
| 83 | MP0009763_increased_sensitivity_to | 0.89144208 |
| 84 | MP0002006_tumorigenesis | 0.88437754 |
| 85 | MP0001188_hyperpigmentation | 0.85960925 |
| 86 | MP0001533_abnormal_skeleton_physiology | 0.85346520 |
| 87 | MP0002405_respiratory_system_inflammati | 0.84135197 |
| 88 | MP0005275_abnormal_skin_tensile | 0.83950516 |
| 89 | MP0001661_extended_life_span | 0.83059777 |
| 90 | MP0009642_abnormal_blood_homeostasis | 0.82490793 |
| 91 | MP0005670_abnormal_white_adipose | 0.82066954 |
| 92 | MP0003045_fibrosis | 0.80139981 |
| 93 | MP0006036_abnormal_mitochondrial_physio | 0.79005432 |
| 94 | MP0000015_abnormal_ear_pigmentation | 0.78011471 |
| 95 | MP0002971_abnormal_brown_adipose | 0.77941718 |
| 96 | MP0008469_abnormal_protein_level | 0.77417672 |
| 97 | MP0004484_altered_response_of | 0.76590438 |
| 98 | MP0001756_abnormal_urination | 0.76386621 |
| 99 | MP0005084_abnormal_gallbladder_morpholo | 0.75985395 |
| 100 | MP0009765_abnormal_xenobiotic_induced | 0.74382679 |
| 101 | MP0005409_darkened_coat_color | 0.73900869 |
| 102 | MP0003329_amyloid_beta_deposits | 0.73580296 |
| 103 | MP0005535_abnormal_body_temperature | 0.73550084 |
| 104 | MP0005376_homeostasis/metabolism_phenot | 0.72739061 |
| 105 | MP0002998_abnormal_bone_remodeling | 0.72460003 |
| 106 | MP0003690_abnormal_glial_cell | 0.69980400 |
| 107 | MP0000579_abnormal_nail_morphology | 0.68911640 |
| 108 | MP0000249_abnormal_blood_vessel | 0.68017413 |
| 109 | MP0002078_abnormal_glucose_homeostasis | 0.67326925 |
| 110 | MP0003705_abnormal_hypodermis_morpholog | 0.65083995 |
| 111 | MP0005220_abnormal_exocrine_pancreas | 0.64722936 |
| 112 | MP0005334_abnormal_fat_pad | 0.64070692 |
| 113 | MP0005395_other_phenotype | 0.63381163 |
| 114 | MP0002136_abnormal_kidney_physiology | 0.58243736 |
| 115 | MP0006035_abnormal_mitochondrial_morpho | 0.56480307 |
| 116 | MP0002822_catalepsy | 0.54856180 |
| 117 | MP0005266_abnormal_metabolism | 0.54199960 |
| 118 | MP0010368_abnormal_lymphatic_system | 0.53197270 |
| 119 | MP0004043_abnormal_pH_regulation | 0.51977534 |
| 120 | MP0005448_abnormal_energy_balance | 0.51561941 |
| 121 | MP0009053_abnormal_anal_canal | 0.51490895 |
| 122 | MP0000639_abnormal_adrenal_gland | 0.49971627 |
| 123 | MP0003638_abnormal_response/metabolism_ | 0.49266048 |
| 124 | MP0004130_abnormal_muscle_cell | 0.47732781 |
| 125 | MP0005666_abnormal_adipose_tissue | 0.47268121 |
| 126 | MP0000427_abnormal_hair_cycle | 0.44419875 |
| 127 | MP0005501_abnormal_skin_physiology | 0.44135783 |
| 128 | MP0000647_abnormal_sebaceous_gland | 0.43637292 |
| 129 | MP0003453_abnormal_keratinocyte_physiol | 0.43455384 |
| 130 | MP0000230_abnormal_systemic_arterial | 0.43247486 |
| 131 | MP0000566_synostosis | 0.43095411 |
| 132 | MP0001765_abnormal_ion_homeostasis | 0.42496954 |
| 133 | MP0002060_abnormal_skin_morphology | 0.42372404 |
| 134 | MP0008874_decreased_physiological_sensi | 0.41320435 |
| 135 | MP0003724_increased_susceptibility_to | 0.41212387 |
| 136 | MP0003953_abnormal_hormone_level | 0.40065998 |
| 137 | MP0004782_abnormal_surfactant_physiolog | 0.40057775 |
| 138 | MP0002098_abnormal_vibrissa_morphology | 0.39734835 |
| 139 | MP0008872_abnormal_physiological_respon | 0.39404403 |
| 140 | MP0009384_cardiac_valve_regurgitation | 0.38809900 |
| 141 | MP0008873_increased_physiological_sensi | 0.37803696 |
| 142 | MP0010234_abnormal_vibrissa_follicle | 0.35842920 |
| 143 | MP0001216_abnormal_epidermal_layer | 0.35807311 |
| 144 | MP0009379_abnormal_foot_pigmentation | 0.35321971 |
| 145 | MP0000538_abnormal_urinary_bladder | 0.32424077 |
| 146 | MP0005248_abnormal_Harderian_gland | 0.31909007 |
| 147 | MP0002928_abnormal_bile_duct | 0.31712442 |
| 148 | MP0000377_abnormal_hair_follicle | 0.30199683 |
| 149 | MP0001243_abnormal_dermal_layer | 0.29814347 |
| 150 | MP0002837_dystrophic_cardiac_calcinosis | 0.29550782 |
| 151 | MP0009672_abnormal_birth_weight | 0.28026891 |
| 152 | MP0009115_abnormal_fat_cell | 0.27259008 |
| 153 | MP0010678_abnormal_skin_adnexa | 0.27250311 |
| 154 | MP0005166_decreased_susceptibility_to | 0.27135374 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.18148727 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 7.12808341 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.81404987 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.28084625 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.26751326 |
| 6 | Xanthomatosis (HP:0000991) | 6.22047487 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 6.11317190 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.48266475 |
| 9 | Chronic diarrhea (HP:0002028) | 5.24241376 |
| 10 | Decreased circulating renin level (HP:0003351) | 5.00658140 |
| 11 | Complement deficiency (HP:0004431) | 4.87528578 |
| 12 | Hyperactive renin-angiotensin system (HP:0000841) | 4.84518456 |
| 13 | Hyperglycinemia (HP:0002154) | 4.76915619 |
| 14 | Hypolipoproteinemia (HP:0010981) | 4.56937579 |
| 15 | Hyperglycinuria (HP:0003108) | 4.52275290 |
| 16 | Hyperammonemia (HP:0001987) | 4.52269944 |
| 17 | Joint hemorrhage (HP:0005261) | 4.47963092 |
| 18 | Epidermoid cyst (HP:0200040) | 4.42861953 |
| 19 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.41315468 |
| 20 | Abnormality of glycine metabolism (HP:0010895) | 4.41315468 |
| 21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.35422994 |
| 22 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.24023864 |
| 23 | Ketosis (HP:0001946) | 4.22951335 |
| 24 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.22517579 |
| 25 | Abnormality of renin-angiotensin system (HP:0000847) | 4.20775866 |
| 26 | Metabolic alkalosis (HP:0200114) | 4.18811594 |
| 27 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.15717352 |
| 28 | Fat malabsorption (HP:0002630) | 4.09704789 |
| 29 | Abnormality of methionine metabolism (HP:0010901) | 4.05650946 |
| 30 | Hypoalphalipoproteinemia (HP:0003233) | 3.98079361 |
| 31 | Abnormality of the common coagulation pathway (HP:0010990) | 3.93923890 |
| 32 | Ileus (HP:0002595) | 3.89934846 |
| 33 | Conjugated hyperbilirubinemia (HP:0002908) | 3.76575207 |
| 34 | Hypoglycemic coma (HP:0001325) | 3.68533796 |
| 35 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.56290130 |
| 36 | Abnormality of complement system (HP:0005339) | 3.51888004 |
| 37 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.51631590 |
| 38 | Hypercholesterolemia (HP:0003124) | 3.34139788 |
| 39 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.30865618 |
| 40 | Abnormality of the intrinsic pathway (HP:0010989) | 3.27280148 |
| 41 | Abnormality of serum amino acid levels (HP:0003112) | 3.24177331 |
| 42 | Eczematoid dermatitis (HP:0000976) | 3.21910564 |
| 43 | Congenital sensorineural hearing impairment (HP:0008527) | 3.21118365 |
| 44 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 3.18018855 |
| 45 | Abnormality of nucleobase metabolism (HP:0010932) | 3.13941463 |
| 46 | Delayed CNS myelination (HP:0002188) | 3.13353750 |
| 47 | Steatorrhea (HP:0002570) | 3.10834514 |
| 48 | Hyperbilirubinemia (HP:0002904) | 3.07162958 |
| 49 | Ketoacidosis (HP:0001993) | 3.07057300 |
| 50 | Abnormality of vitamin B metabolism (HP:0004340) | 3.01423605 |
| 51 | Widely patent fontanelles and sutures (HP:0004492) | 3.00471637 |
| 52 | Abnormality of purine metabolism (HP:0004352) | 2.92767130 |
| 53 | Metabolic acidosis (HP:0001942) | 2.91634882 |
| 54 | Gout (HP:0001997) | 2.89526324 |
| 55 | Lethargy (HP:0001254) | 2.86566139 |
| 56 | Plantar hyperkeratosis (HP:0007556) | 2.85152927 |
| 57 | Dicarboxylic aciduria (HP:0003215) | 2.82360356 |
| 58 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.82360356 |
| 59 | Vascular calcification (HP:0004934) | 2.81698689 |
| 60 | Right ventricular cardiomyopathy (HP:0011663) | 2.73058146 |
| 61 | Spontaneous abortion (HP:0005268) | 2.70433735 |
| 62 | Pustule (HP:0200039) | 2.66543912 |
| 63 | Myocardial infarction (HP:0001658) | 2.66275705 |
| 64 | Hepatocellular carcinoma (HP:0001402) | 2.66081610 |
| 65 | Hypochromic microcytic anemia (HP:0004840) | 2.66059816 |
| 66 | Cerebral edema (HP:0002181) | 2.62885641 |
| 67 | Pili torti (HP:0003777) | 2.61833123 |
| 68 | Abnormality of chloride homeostasis (HP:0011422) | 2.61587432 |
| 69 | Vasculitis (HP:0002633) | 2.61366122 |
| 70 | Palmoplantar hyperkeratosis (HP:0000972) | 2.59916712 |
| 71 | Increased IgE level (HP:0003212) | 2.58547257 |
| 72 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.56741190 |
| 73 | Villous atrophy (HP:0011473) | 2.56741190 |
| 74 | Malnutrition (HP:0004395) | 2.51748146 |
| 75 | Abnormality of T cell number (HP:0011839) | 2.51665674 |
| 76 | Skin nodule (HP:0200036) | 2.51409449 |
| 77 | Hyperaldosteronism (HP:0000859) | 2.51306678 |
| 78 | Irritability (HP:0000737) | 2.45819280 |
| 79 | Cardiovascular calcification (HP:0011915) | 2.45594055 |
| 80 | Recurrent bronchitis (HP:0002837) | 2.43928830 |
| 81 | Gastrointestinal stroma tumor (HP:0100723) | 2.43512834 |
| 82 | Systemic lupus erythematosus (HP:0002725) | 2.43347548 |
| 83 | Enlarged epiphyses (HP:0010580) | 2.42138721 |
| 84 | Abnormality of the costochondral junction (HP:0000919) | 2.41785809 |
| 85 | Onycholysis (HP:0001806) | 2.39830783 |
| 86 | Palmar hyperkeratosis (HP:0010765) | 2.39756676 |
| 87 | Hypokalemia (HP:0002900) | 2.39272887 |
| 88 | Abdominal distention (HP:0003270) | 2.38051370 |
| 89 | Acanthocytosis (HP:0001927) | 2.36898343 |
| 90 | Abnormal hair laboratory examination (HP:0003328) | 2.34835341 |
| 91 | Alopecia of scalp (HP:0002293) | 2.31976824 |
| 92 | Generalized aminoaciduria (HP:0002909) | 2.31716893 |
| 93 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.31371010 |
| 94 | T lymphocytopenia (HP:0005403) | 2.31321433 |
| 95 | Dehydration (HP:0001944) | 2.30959477 |
| 96 | Woolly hair (HP:0002224) | 2.29592382 |
| 97 | Rickets (HP:0002748) | 2.29089054 |
| 98 | Abnormality of potassium homeostasis (HP:0011042) | 2.28311890 |
| 99 | Thin bony cortex (HP:0002753) | 2.27153983 |
| 100 | Hypophosphatemic rickets (HP:0004912) | 2.25228088 |
| 101 | Glycosuria (HP:0003076) | 2.25191578 |
| 102 | Abnormality of urine glucose concentration (HP:0011016) | 2.25191578 |
| 103 | Alkalosis (HP:0001948) | 2.25178744 |
| 104 | Vomiting (HP:0002013) | 2.24901882 |
| 105 | Glomerulonephritis (HP:0000099) | 2.23554934 |
| 106 | Enlarged kidneys (HP:0000105) | 2.23425978 |
| 107 | Flat acetabular roof (HP:0003180) | 2.23322128 |
| 108 | Brushfield spots (HP:0001088) | 2.23251743 |
| 109 | Stomach cancer (HP:0012126) | 2.21442512 |
| 110 | Spastic diplegia (HP:0001264) | 2.21196175 |
| 111 | Pancreatitis (HP:0001733) | 2.20732857 |
| 112 | Proximal tubulopathy (HP:0000114) | 2.20601911 |
| 113 | Abnormal gallbladder morphology (HP:0012437) | 2.19440765 |
| 114 | Amyloidosis (HP:0011034) | 2.19371080 |
| 115 | Hypoglycemic seizures (HP:0002173) | 2.18952769 |
| 116 | Neonatal onset (HP:0003623) | 2.17107763 |
| 117 | Agammaglobulinemia (HP:0004432) | 2.14466582 |
| 118 | Milia (HP:0001056) | 2.13371138 |
| 119 | Abnormality of B cell number (HP:0010975) | 2.12826479 |
| 120 | Fragile nails (HP:0001808) | 2.11970344 |
| 121 | Abnormality of T cells (HP:0002843) | 2.11583641 |
| 122 | Renal cortical cysts (HP:0000803) | 2.11024740 |
| 123 | Cholelithiasis (HP:0001081) | 2.10773921 |
| 124 | Cholecystitis (HP:0001082) | 2.09827981 |
| 125 | Abnormal gallbladder physiology (HP:0012438) | 2.09827981 |
| 126 | Pigmentary retinal degeneration (HP:0001146) | 2.08286888 |
| 127 | Hyperuricemia (HP:0002149) | 2.05487261 |
| 128 | Increased purine levels (HP:0004368) | 2.05487261 |
| 129 | Abnormality of proline metabolism (HP:0010907) | 2.05480262 |
| 130 | Hydroxyprolinuria (HP:0003080) | 2.05480262 |
| 131 | Abnormality of macrophages (HP:0004311) | 2.03845205 |
| 132 | Sensorimotor neuropathy (HP:0007141) | 2.03245889 |
| 133 | Opisthotonus (HP:0002179) | 2.03194233 |
| 134 | Pulmonary infiltrates (HP:0002113) | 2.02945545 |
| 135 | Abnormality of T cell physiology (HP:0011840) | 2.02312288 |
| 136 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.02189446 |
| 137 | Posterior subcapsular cataract (HP:0007787) | 2.01322107 |
| 138 | Hematochezia (HP:0002573) | 1.98615800 |
| 139 | Chronic otitis media (HP:0000389) | 1.98256843 |
| 140 | Nausea (HP:0002018) | 1.98091439 |
| 141 | Recurrent sinusitis (HP:0011108) | 1.96778042 |
| 142 | Mitral stenosis (HP:0001718) | 1.95646174 |
| 143 | Premature loss of primary teeth (HP:0006323) | 1.95234153 |
| 144 | Abnormality of vitamin metabolism (HP:0100508) | 1.94512495 |
| 145 | Menorrhagia (HP:0000132) | 1.93387660 |
| 146 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.91887205 |
| 147 | Recurrent pneumonia (HP:0006532) | 1.91790595 |
| 148 | Metaphyseal irregularity (HP:0003025) | 1.90988334 |
| 149 | Hemoptysis (HP:0002105) | 1.90905178 |
| 150 | Skin rash (HP:0000988) | 1.89659036 |
| 151 | Hyperkalemia (HP:0002153) | 1.89240325 |
| 152 | Gingival bleeding (HP:0000225) | 1.88844107 |
| 153 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.88636854 |
| 154 | Confusion (HP:0001289) | 1.88234482 |
| 155 | Hyperparathyroidism (HP:0000843) | 1.87482564 |
| 156 | Nephrolithiasis (HP:0000787) | 1.87460538 |
| 157 | Late onset (HP:0003584) | 1.87074005 |
| 158 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.86525698 |
| 159 | Autoimmune hemolytic anemia (HP:0001890) | 1.86414905 |
| 160 | Dry hair (HP:0011359) | 1.85718058 |
| 161 | Recurrent bacterial skin infections (HP:0005406) | 1.85051075 |
| 162 | Abnormal albumin level (HP:0012116) | 1.84973310 |
| 163 | Hypoalbuminemia (HP:0003073) | 1.84973310 |
| 164 | Abnormality of glycolipid metabolism (HP:0010969) | 1.84843533 |
| 165 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.84843533 |
| 166 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.84843533 |
| 167 | Esophageal varix (HP:0002040) | 1.83843995 |
| 168 | Vacuolated lymphocytes (HP:0001922) | 1.82930402 |
| 169 | Hemorrhage of the eye (HP:0011885) | 1.82445563 |
| 170 | Abnormality of the gallbladder (HP:0005264) | 1.82241174 |
| 171 | IgM deficiency (HP:0002850) | 1.81117151 |
| 172 | IgG deficiency (HP:0004315) | 1.80164785 |
| 173 | Renal tubular acidosis (HP:0001947) | 1.79896783 |
| 174 | Thick nail (HP:0001805) | 1.79553980 |
| 175 | Increased circulating renin level (HP:0000848) | 1.79401368 |
| 176 | Abnormal blistering of the skin (HP:0008066) | 1.76686010 |
| 177 | Autoimmune thrombocytopenia (HP:0001973) | 1.75319839 |
| 178 | Abnormality of the nasal mucosa (HP:0000433) | 1.75142244 |
| 179 | Abnormal cartilage morphology (HP:0002763) | 1.75120601 |
| 180 | Abnormality of magnesium homeostasis (HP:0004921) | 1.74726000 |
| 181 | Meningitis (HP:0001287) | 1.74209482 |
| 182 | Elevated hepatic transaminases (HP:0002910) | 1.73119272 |
| 183 | Thrombophlebitis (HP:0004418) | 1.72927020 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.03426230 |
| 2 | ACVR1B | 5.58656927 |
| 3 | FGFR4 | 4.23515697 |
| 4 | MAP4K1 | 3.79603350 |
| 5 | TXK | 3.77086238 |
| 6 | SIK1 | 3.45848790 |
| 7 | ERN1 | 3.33361470 |
| 8 | INSRR | 3.28451948 |
| 9 | ERBB4 | 3.08711082 |
| 10 | MST1R | 2.99879562 |
| 11 | RIPK4 | 2.64384335 |
| 12 | TAOK3 | 2.58591762 |
| 13 | STK24 | 2.58272720 |
| 14 | MAP2K4 | 2.02439911 |
| 15 | PIK3CG | 1.98518441 |
| 16 | LATS1 | 1.90918117 |
| 17 | PRKG2 | 1.90096472 |
| 18 | FRK | 1.89586663 |
| 19 | OXSR1 | 1.79288204 |
| 20 | FGFR2 | 1.78888764 |
| 21 | STK38L | 1.76953927 |
| 22 | BMPR2 | 1.70891879 |
| 23 | MST4 | 1.66367481 |
| 24 | MAPK11 | 1.61387486 |
| 25 | STK39 | 1.59663249 |
| 26 | ABL2 | 1.50889112 |
| 27 | MAP3K12 | 1.50116067 |
| 28 | MAP3K2 | 1.43794132 |
| 29 | NLK | 1.42913508 |
| 30 | PRKAA2 | 1.36288173 |
| 31 | EPHB1 | 1.36026318 |
| 32 | MET | 1.34628820 |
| 33 | ITK | 1.33818092 |
| 34 | WNK4 | 1.32302844 |
| 35 | LMTK2 | 1.28648051 |
| 36 | MAPKAPK3 | 1.28271739 |
| 37 | MAPK15 | 1.26929418 |
| 38 | RIPK1 | 1.24826346 |
| 39 | TEC | 1.21654001 |
| 40 | IKBKB | 1.20836139 |
| 41 | MAP3K10 | 1.20071406 |
| 42 | MATK | 1.20005631 |
| 43 | WNK3 | 1.19567653 |
| 44 | SYK | 1.19141424 |
| 45 | PINK1 | 1.18733534 |
| 46 | ZAP70 | 1.15016246 |
| 47 | BTK | 1.13612636 |
| 48 | NME2 | 1.13350214 |
| 49 | PKN1 | 1.12867259 |
| 50 | GRK1 | 1.12174443 |
| 51 | PBK | 1.11264017 |
| 52 | IRAK3 | 1.10255251 |
| 53 | EPHA4 | 1.10203263 |
| 54 | TYK2 | 1.07557130 |
| 55 | MAPK4 | 1.07477428 |
| 56 | JAK3 | 1.05885259 |
| 57 | TESK1 | 1.04636800 |
| 58 | MAP3K3 | 1.03983979 |
| 59 | MAP3K1 | 1.02927277 |
| 60 | ERBB2 | 1.01241581 |
| 61 | MAP3K11 | 1.00829306 |
| 62 | MAP3K7 | 0.99552534 |
| 63 | DAPK2 | 0.98407580 |
| 64 | TESK2 | 0.97534835 |
| 65 | PRKCZ | 0.97459502 |
| 66 | PTK6 | 0.96855019 |
| 67 | TGFBR2 | 0.96104643 |
| 68 | GRK6 | 0.95598877 |
| 69 | EPHA3 | 0.95011764 |
| 70 | CSNK1G1 | 0.94022106 |
| 71 | CAMK2G | 0.92065674 |
| 72 | PDK4 | 0.91611305 |
| 73 | PDK3 | 0.91611305 |
| 74 | ADRBK2 | 0.91255417 |
| 75 | GSK3A | 0.88605458 |
| 76 | FGFR3 | 0.88498899 |
| 77 | STK16 | 0.88384920 |
| 78 | LCK | 0.88140250 |
| 79 | JAK2 | 0.87574806 |
| 80 | NEK9 | 0.87487607 |
| 81 | MAP3K14 | 0.79327847 |
| 82 | NUAK1 | 0.77778648 |
| 83 | PRKACG | 0.75961543 |
| 84 | LYN | 0.75729958 |
| 85 | PASK | 0.74782039 |
| 86 | PRKAA1 | 0.74167574 |
| 87 | KDR | 0.73839074 |
| 88 | TIE1 | 0.72395415 |
| 89 | CSNK1G3 | 0.72146137 |
| 90 | FLT3 | 0.71699555 |
| 91 | MAPK12 | 0.71438153 |
| 92 | IRAK4 | 0.71398795 |
| 93 | PDK1 | 0.68669823 |
| 94 | DYRK1B | 0.68461488 |
| 95 | IRAK2 | 0.67188519 |
| 96 | PDK2 | 0.66863161 |
| 97 | CSNK1G2 | 0.66466422 |
| 98 | MAP2K6 | 0.65219304 |
| 99 | MAP3K6 | 0.64702331 |
| 100 | BLK | 0.62765270 |
| 101 | KIT | 0.62527204 |
| 102 | SGK223 | 0.62175858 |
| 103 | SGK494 | 0.62175858 |
| 104 | IRAK1 | 0.62150427 |
| 105 | TRPM7 | 0.61957764 |
| 106 | PRKCQ | 0.61596529 |
| 107 | TNIK | 0.60694517 |
| 108 | PDPK1 | 0.58617684 |
| 109 | JAK1 | 0.57871184 |
| 110 | TGFBR1 | 0.56712862 |
| 111 | CDK6 | 0.55278456 |
| 112 | MARK3 | 0.54872822 |
| 113 | CSNK1A1L | 0.53581332 |
| 114 | CSF1R | 0.52739725 |
| 115 | CAMKK2 | 0.52514702 |
| 116 | HCK | 0.51440713 |
| 117 | CSK | 0.50931148 |
| 118 | MAP2K2 | 0.50680419 |
| 119 | PRKCG | 0.49287528 |
| 120 | TBK1 | 0.49207243 |
| 121 | PIK3CA | 0.47758330 |
| 122 | MYLK | 0.46919915 |
| 123 | BCR | 0.46699284 |
| 124 | PIM1 | 0.46545694 |
| 125 | SIK3 | 0.46051578 |
| 126 | MAPKAPK2 | 0.45257513 |
| 127 | DDR2 | 0.44643414 |
| 128 | PAK3 | 0.43911585 |
| 129 | FER | 0.43627738 |
| 130 | BMPR1B | 0.43537173 |
| 131 | CDC42BPA | 0.43358863 |
| 132 | MAPK7 | 0.42130780 |
| 133 | MAP2K1 | 0.41744015 |
| 134 | STK3 | 0.41571723 |
| 135 | AKT3 | 0.41543075 |
| 136 | CAMK1D | 0.41040344 |
| 137 | EPHB2 | 0.40480237 |
| 138 | PTK2 | 0.39843886 |
| 139 | CHUK | 0.38533983 |
| 140 | IGF1R | 0.38190791 |
| 141 | STK10 | 0.37159798 |
| 142 | PRKCA | 0.37070483 |
| 143 | CASK | 0.35089422 |
| 144 | EPHA2 | 0.34253905 |
| 145 | PRKACA | 0.33186377 |
| 146 | MAP3K13 | 0.33070814 |
| 147 | PKN2 | 0.32894547 |
| 148 | IKBKE | 0.32475119 |
| 149 | LATS2 | 0.31859163 |
| 150 | SGK2 | 0.29628277 |
| 151 | SGK3 | 0.27286991 |
| 152 | MAP2K3 | 0.26523965 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.24962340 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.24938940 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.18548297 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.94284016 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.86186899 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.80060848 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 2.78105102 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.72036494 |
| 9 | Asthma_Homo sapiens_hsa05310 | 2.69342775 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.66865168 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.64666093 |
| 12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.63805496 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.60711330 |
| 14 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.55748232 |
| 15 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.49054932 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.48792510 |
| 17 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.48114955 |
| 18 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.36943168 |
| 19 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.34919224 |
| 20 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.25051498 |
| 21 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.20466119 |
| 22 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.16577141 |
| 23 | Peroxisome_Homo sapiens_hsa04146 | 2.14487679 |
| 24 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.07348260 |
| 25 | Histidine metabolism_Homo sapiens_hsa00340 | 2.05625857 |
| 26 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.98038199 |
| 27 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.97622332 |
| 28 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.95928226 |
| 29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.94646997 |
| 30 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.94419191 |
| 31 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.89976035 |
| 32 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.88481445 |
| 33 | Retinol metabolism_Homo sapiens_hsa00830 | 1.85234433 |
| 34 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.84369351 |
| 35 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.75567354 |
| 36 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.73974872 |
| 37 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.63747097 |
| 38 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.62274326 |
| 39 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.60565224 |
| 40 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.60463399 |
| 41 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.58228720 |
| 42 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.55203929 |
| 43 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.52169029 |
| 44 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.50978400 |
| 45 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.50606342 |
| 46 | Bile secretion_Homo sapiens_hsa04976 | 1.47667490 |
| 47 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.46693237 |
| 48 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.45546207 |
| 49 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.43660825 |
| 50 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.39984884 |
| 51 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.39965188 |
| 52 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.38807617 |
| 53 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.36190400 |
| 54 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.36078501 |
| 55 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.31230612 |
| 56 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.28988248 |
| 57 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.20655016 |
| 58 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.20395969 |
| 59 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.19589816 |
| 60 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.18758899 |
| 61 | Leishmaniasis_Homo sapiens_hsa05140 | 1.18143155 |
| 62 | ABC transporters_Homo sapiens_hsa02010 | 1.14955687 |
| 63 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.12132559 |
| 64 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.08499763 |
| 65 | Carbon metabolism_Homo sapiens_hsa01200 | 1.07818196 |
| 66 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.05202683 |
| 67 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.05102476 |
| 68 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.04501411 |
| 69 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.98608080 |
| 70 | Viral myocarditis_Homo sapiens_hsa05416 | 0.98342514 |
| 71 | Sulfur relay system_Homo sapiens_hsa04122 | 0.92047921 |
| 72 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.90411733 |
| 73 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.89155991 |
| 74 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.88142613 |
| 75 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.86630554 |
| 76 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.86322500 |
| 77 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.82031105 |
| 78 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.80900868 |
| 79 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.79490027 |
| 80 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.77653371 |
| 81 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.77553137 |
| 82 | Lysine degradation_Homo sapiens_hsa00310 | 0.72803654 |
| 83 | Tuberculosis_Homo sapiens_hsa05152 | 0.67539467 |
| 84 | Other glycan degradation_Homo sapiens_hsa00511 | 0.64208008 |
| 85 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.61802411 |
| 86 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.61031052 |
| 87 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.60168499 |
| 88 | Influenza A_Homo sapiens_hsa05164 | 0.58635415 |
| 89 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.57633391 |
| 90 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.57140408 |
| 91 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56950390 |
| 92 | Pertussis_Homo sapiens_hsa05133 | 0.55751095 |
| 93 | Metabolic pathways_Homo sapiens_hsa01100 | 0.55179837 |
| 94 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.52206450 |
| 95 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.51754173 |
| 96 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.51539813 |
| 97 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.49326571 |
| 98 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.49275024 |
| 99 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.45020642 |
| 100 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.42022283 |
| 101 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.42020450 |
| 102 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.41935247 |
| 103 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.41487862 |
| 104 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.40893964 |
| 105 | Phagosome_Homo sapiens_hsa04145 | 0.37181466 |
| 106 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.36686967 |
| 107 | Lysosome_Homo sapiens_hsa04142 | 0.36302347 |
| 108 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.35987369 |
| 109 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.35436145 |
| 110 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.34779562 |
| 111 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.33031747 |
| 112 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.30631380 |
| 113 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.29824252 |
| 114 | Prion diseases_Homo sapiens_hsa05020 | 0.22455644 |
| 115 | Renin secretion_Homo sapiens_hsa04924 | 0.22234939 |
| 116 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.22216368 |
| 117 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.20400622 |
| 118 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.18967218 |
| 119 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.15408928 |
| 120 | Galactose metabolism_Homo sapiens_hsa00052 | 0.14152668 |
| 121 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.12928627 |
| 122 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.10567907 |
| 123 | Insulin resistance_Homo sapiens_hsa04931 | 0.10462865 |
| 124 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.06417829 |
| 125 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.02671256 |
| 126 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.01514191 |
| 127 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.00277921 |
| 128 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.2276828 |
| 129 | Parkinsons disease_Homo sapiens_hsa05012 | -0.2255131 |
| 130 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.2227157 |
| 131 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2095821 |
| 132 | Alzheimers disease_Homo sapiens_hsa05010 | -0.2002790 |
| 133 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1957397 |
| 134 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.1953271 |
| 135 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1904325 |
| 136 | Hepatitis C_Homo sapiens_hsa05160 | -0.1878881 |
| 137 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1803591 |
| 138 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1774339 |
| 139 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1516643 |
| 140 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0837687 |
| 141 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.0654213 |
| 142 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0275969 |
| 143 | Mineral absorption_Homo sapiens_hsa04978 | -0.0228130 |
| 144 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0206449 |

